Curi Bio is proud to announce the signing of a seven-year lease for a 13,942-square-foot space at BioMed Realty's 201 Elliott Avenue West in Seattle. This strategic milestone will enable Curi Bio to expand its research and development efforts, advancing its mission to unlock critical human data that informs biopharmaceutical R&D decision-making. Read the press release for more details: https://hubs.ly/Q02Md3F90 #TranslationalResearch #3DMuscleTissue #3DTissues #EngineeredTissues #PressRelease #SeattleBiotech
Curi Bio
Biotechnology Research
Seattle, Washington 5,620 followers
Human Data for Next Generation Medicines
Über uns
"Human Data for Next Generation Medicines" Curi Bio unlocks novel workflows and critical human data to inform R&D decision-making. Through an integrated platform featuring advanced 3D tissue models of disease, biosystems enabling clinically relevant functional analyses, and AI/ML-enabled insights, Curi Bio merges functional and analytical assessments for drug safety, efficacy, and potency
- Website
-
https://www.curibio.com
External link for Curi Bio
- Industrie
- Biotechnology Research
- Größe des Unternehmens
- 11-50 Mitarbeiter
- Hauptsitz
- Seattle, Washington
- Typ
- In Privatbesitz
- Gegründet
- 2015
- Spezialitäten
- biotechnology, tissue engineering, stem cell biology, mechanobiology, drug screening, drug development, high-throughput screening, iPSC-CM, disease modeling, cell biology, drug discovery, and hiPSC
Standorte
-
Primäre
Wegbeschreibung erhalten
3000 Western Ave
Seattle, Washington 98121, US
Employees at Curi Bio
Aktualisierungen
-
Thank you BioMed Realty for being great partners and helping us secure this location. We're very excited for the big move!
BioMed Realty has executed a lease with Curi Bio for 13,942 feet of lab and office space at 201 Elliott Avenue West in Seattle! The seven-year lease will enable Curi Bio to expand its research and development efforts, advancing its mission to unlock critical human data that informs biopharmaceutical R&D decision-making through its integrated preclinical platform. The company’s cutting-edge technologies utilize human stem cell-based models and advanced biosystems to generate clinically relevant data. This approach bridges the gap between preclinical research and clinical outcomes, accelerating the development of the next generation of medicines. Curi Bio team: Welcome to 201 Elliott! The property features an array of carefully curated tenant amenities to inspire innovation, including a fitness center, a courtyard, a newly renovated cafe, and reserved underground parking. For more on Curi Bio and its move, access Puget Sound Business Journal’s coverage: https://lnkd.in/g4RVBbTT.
-
-
Curi Bio is excited to announce the beta launch of our latest innovation – Cardiac Muscle Media, specifically optimized for human 3D cardiac tissue experiments. Register now to join our exclusive early access program and advance your heart tissue experiments with more physiologically relevant media: : https://hubs.ly/Q02Lmm9x0 #3Dtissues #CellCulture #DrugDiscovery #TranslationalResearch #EngineeredTissues #Cardiac
-
-
If you're in Estérel, Quebec this week for the "Skeletal Muscle Stem Cells in Development Regenerations & Adaptations" conference, make sure you take the opportunity to meet in-person with our very own Dr. Greg Luerman. Also, stop by and chat with the Entrada Therapeutics team to learn about the great work they're doing! #DMD #DuchenneMuscularDystrophy
-
-
#TERMIS2024 attendees, don't miss this oral presentation on Thursday (tomorrow) starting at 3:45pm, presented by Curi Bio's Dr. Shawn Luttrell. If you're interested in chatting with a Curi Bio team member in-person while you're here, please reach out to [email protected]. #DMD #DuchenneMuscularDystrophy #Seattle
-
-
At TERMIS in Seattle? Visit Booth #407 to see how NEXEL and Curi Bio can help with your 3D tissue experiments! #TERMIS2024 #Seattle
-
-
In #Seattle this week for TERMIS 2024? Be sure to check out our poster presentation tomorrow (Wednesday) from 6:15-7:45pm! If you're interested in connecting in-person with Curi Bio in-person, please reach out to [email protected]. #NeuromuscularJunction #TERMIS2024
-
-
In Ft. Lauderdale this week for UF Myology Institute's New Directions in Biology and Disease of Skeletal Muscle Conference? Be sure to check out our poster presentation! If you're interested in connecting in-person with Curi Bio's Dr. Greg Luerman while he's there, please reach out to [email protected]. #SkeletalMuscle #DM1 #XLMTM #NeuromuscularJunction
-
-
Our #workshop in Seattle last week was a success! We were able to learn from a handful of informative scientific talks on #SkeletalMuscle #Cardiac and #NeuromuscularJunction models and two hands-on demos, all in one day! Thank you to all our attendees for your participation and great questions. Another big thank you to our lineup of speakers for their great insight and data: David Mack (University of Washington) Erik Sandoval (Cytokinetics) Nelsa Estrella, Ph.D. (Entrada Therapeutics) Shawn Luttrell Arefin Ayesha Jacob Fleming We're looking forward to similar workshops in the future! If you're interested in attending one of our workshops covering new and emerging technologies in advanced #3Dtissues for disease modeling, #DrugDiscovery, and regenerative medicine applications, be sure to join our newsletter to be in-the-know as soon as we announce our next workshop details! For more information on this workshop visit our website: https://lnkd.in/g_bdVNk2
-
-
Reminder to #MPSWorldSummit attendees: don't miss Curi Bio's Dr. Nicholas Geisse's oral presentation today, starting at 3:40pm in Room 323/325! More details: https://hubs.ly/Q02BqyRd0 PS. Since you're already in town, check out our workshop on Friday! Secure your spot: https://hubs.ly/Q02Bq5YY0 #Seattle #3Dtissues #EngineeredTissues #DrugDiscovery #DMD #SkeletalMuscle #DuchenneMuscularDystrophy
-